India FSSAI Acts Against GLP-1 Supplement for Misleading Claims
First reported 8 Oct, 16:10 UTCUpdated 2d ago5 sources
1 left · 4 center · 0 right · Full breakdown
Polyview Briefing
AI-generatedFSSAI issued notices to Dr Reddy's, Nestle Health Science and several online retailers over allegedly misleading health claims on protein/GLP-1 supplement products, saying the claims could mislead consumers about benefits.
How the Left framed it
Deccan Herald says notices were sent to Dr Reddy's, Nestle Health Science, Tirupati Wellness, Flipkart, Amazon and Netmeds for selling products with misleading claims of high protein support for maintaining lean muscles.
How the Center framed it
Center outlets (Bloomberg, Mint, CNBC-TV18, NDTV) say FSSAI sent notices to Dr Reddy's and Nestle Health Science (or their joint venture) regarding misleading claims about a GLP-1 supplement (Celevida GLP+) and that the claims on packaging could mislead consumers about health benefits; some also note Amazon and Flipkart as recipients.
How the Right framed it
No right-leaning coverage yet.
What everyone reports
- FSSAI issued notices to Dr Reddy's and Nestle Health Science (or their joint venture)
- The notices concern allegedly misleading health claims on supplement products
- The regulator said the claims could potentially mislead consumers about health benefits
Where coverage differs
- Left-leaning outlets (Deccan Herald) emphasise the misleading claim as 'high protein support for maintaining lean muscles', while centre outlets (Bloomberg, Mint, CNBC-TV18, NDTV) focus on misleading claims about a GLP-1 supplement (Celevida GLP+).
- Left-leaning outlets list additional companies Tirupati Wellness and Netmeds among those notified; centre outlets vary, with Bloomberg and CNBC-TV18 mentioning only the Dr Reddy-Nestle joint venture, while Mint and NDTV include Amazon and Flipkart.
- Left-leaning outlets describe the claims as being on products generally; centre outlet NDTV specifically states the claims were presented on product packaging in a manner that could mislead consumers, whereas other centre outlets do not mention packaging expl…
Written by AI from the headlines and excerpts of 5 outlets (OpenRouter) on 9 Oct, 03:35 UTC. It can make mistakes — read the original reporting below. How briefings work
Compare the headlines
How outlets on each side framed it
New Delhi: Food regulator FSSAI has issued notices to Dr Reddy's, Nestle Health Science, Tirupati Wellness, Flipkart, Amazon and Netmeds for selling products with misleading claims of high protein support for maintaining lean muscles. FSSAI takes action against M/s Dr. Reddy’s and Nestle Health Science Limited, M/s…
India’s federal food regulator issued a notice to the joint venture between Dr. Reddy’s Laboratories Ltd. and Nestle India Ltd. for misleading and ambiguous claims about its GLP-1 supplement.
No right-leaning outlet in our index has covered this yet.
Full coverage
5 outlets — tap a headline to read it at the source
- India FSSAI Acts Against GLP-1 Supplement for Misleading Claims (opens Bloomberg in a new tab)
India’s federal food regulator issued a notice to the joint venture between Dr. Reddy’s Laboratories Ltd. and Nestle India Ltd. for misleading and ambiguous claims about its GLP-1 supplement.
- FSSAI issues notices to Dr Reddy's, Nestle Health Science, Amazon, Flipkart for misleading claims (opens Deccan Herald in a new tab)
New Delhi: Food regulator FSSAI has issued notices to Dr Reddy's, Nestle Health Science, Tirupati Wellness, Flipkart, Amazon and Netmeds for selling products with misleading claims of high protein support for maintaining lean muscles. FSSAI takes action against M/s Dr. Reddy’s and Nestle Health Science Limited, M/s…
- FSSAI send notices to Dr Reddy's, Nestle Health Science, Amazon, Flipkart over misleading protein supplement (opens Mint in a new tab)
The Food Safety and Standards Authority of India (FSSAI) has sent notices to companies, including Dr Reddy's and Nestle Health Science, regarding products which can possibly mislead consumers regarding its health benefits. It issued notices for non-compliant advertising and misleading claims.
- India’s food regulator acts against GLP-1 supplement for misleading claims (opens CNBC-TV18 in a new tab)
India's food regulator, FSSAI, issued a notice to Dr Reddy's and Nestle India's joint venture for misleading claims regarding their Celevida GLP+ supplement.
- Dr Reddy's, Nestle, Amazon, Flipkart Get Notice Over Misleading Health Claims (opens NDTV in a new tab)
The regulator said such claims were presented on product packaging in a manner that could potentially mislead consumers about the health benefits associated with the products.
